UCL Institute of Neurology
Research and teaching excellence
The Institute of Neurology has a world class reputation for neuroscience. The mission is to translate neuroscience discovery research into treatments for patients with neurological diseases. A number of important research centres are based at the Institute, including the MRC Centre for Neuromuscular Diseases and the Wellcome Centre for Human Neuroimaging
The hub of the research activities and operational headquarters of the UK Dementia Research Institute (DRI) are also at UCL, embedded within the Institute.
Professor Michael Hanna is the Director of the Institute, which is a specialist postgraduate institute of University College London, the top-ranked university in the UK for research in Psychology, Psychiatry and Neuroscience.
The Institute is closely associated in its work with the National Hospital for Neurology & Neurosurgery. In combination they form a national and international centre at Queen Square for teaching, training and research in neurology and allied clinical and basic neurosciences.
What We Do
Please see our Infographic highlighting key data on the Institute.
Machine learning could improve our ability to determine whether a new drug works in the brain, potentially enabling researchers to detect drug effects that would be missed entirely by conventional statistical tests, finds a new study led by UCL Institute of Neurology, published today in Brain.
Published: Nov 15, 2017 1:12:04 PM
This year's annual address, held on 7th November 2017, began with a review of the year's successes presented by Professor Michael Hanna, Director of UCL Institute of Neurology.
Published: Nov 10, 2017 1:46:07 PM
Professor Sarah Tabrizi, director of the UCL Huntington’s Disease Centre at the UCL Institute of Neurology, has received the 2017 International Leslie Gehry Brenner prize for Innovation in Science.
Published: Nov 9, 2017 2:29:31 PM